Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome: a randomized, controlled trial

Harry Pickering, John D. Hart, Sarah Burr, Richard Stabler, Ken Maleta, Khumbo Kalua, Robin L. Bailey, Martin J. Holland
doi: https://doi.org/10.1101/2021.03.02.20215632

Article usage

Article usage: March 2021 to June 2025

AbstractFullPdf
Mar 20212975439
Apr 20211201916
May 2021951318
Jun 2021921316
Jul 2021421410
Aug 2021661610
Sep 202144918
Oct 202134722
Nov 2021401223
Dec 20215284
Jan 20222498
Feb 20222352
Mar 20221434
Apr 20221463
May 202223514
Jun 202221665
Jul 202213355
Aug 20222343
Sep 20223689
Oct 202232111
Nov 20221957
Dec 202215213
Jan 20231628
Feb 20231244
Mar 202317511
Apr 20231931
May 20231132
Jun 20231170
Jul 2023633
Aug 202318115
Sep 2023863
Oct 2023623
Nov 20231252
Dec 2023701
Jan 20241833
Feb 20242214
Mar 2024847
Apr 2024898
May 2024132
Jun 20241433
Jul 20241228
Aug 2024949
Sep 20242348
Oct 2024534
Nov 2024908
Dec 2024958
Jan 20251169
Feb 202515368
Mar 202515327
Apr 2025191510
May 2025182420
Jun 2025441418
Back to top
Posted March 03, 2021.
Download PDF
Data/Code
Email
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome: a randomized, controlled trial
Harry Pickering, John D. Hart, Sarah Burr, Richard Stabler, Ken Maleta, Khumbo Kalua, Robin L. Bailey, Martin J. Holland
medRxiv 2021.03.02.20215632; doi: https://doi.org/10.1101/2021.03.02.20215632
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area